Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma
博士 === 國立中興大學 === 生物醫學研究所 === 104 === Although targeted therapy can prolong the survival of non-small cell lung cancer (NSCLC) patients with EGFR mutations, chemotherapy still is the choice for patients with wild-type EGFR or failure in targeted therapy. However, most of the patients will eventually...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/72764055144925664774 |